GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 17 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $595,000 | +801.5% | 50,000 | +270.7% | 0.28% | +389.5% |
| Q1 2016 | $66,000 | -27.5% | 13,488 | +12.5% | 0.06% | -29.6% |
| Q4 2015 | $91,000 | +106.8% | 11,988 | +104.2% | 0.08% | +84.1% |
| Q3 2015 | $44,000 | -95.2% | 5,871 | -96.3% | 0.04% | -93.9% |
| Q4 2014 | $917,000 | -8.8% | 158,121 | +35.2% | 0.72% | -28.6% |
| Q3 2014 | $1,006,000 | -49.9% | 116,987 | -43.2% | 1.02% | -46.6% |
| Q2 2014 | $2,007,000 | -13.4% | 206,100 | +2.0% | 1.90% | -4.5% |
| Q1 2014 | $2,318,000 | – | 202,100 | – | 1.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
| Virtu Financial LLC | 31,633 | $13 | 0.00% |
| Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
| Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
| TSFG, LLC | 3,000 | $1 | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
| Allworth Financial LP | 250 | $107 | 0.00% |
| JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |